ReviewChinese journal of integrative medicine2019
Current Status and Problem-Solving Strategies for Ginseng Industry.
Review in Chinese journal of integrative medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 28 citations in OpenAlex.
- PnWRKY38-PnSUS1 axis regulates the biosynthesis ofHorticulture research · 2026Article
- Sustainable Production of Ginsenosides: Advances in Biosynthesis and Metabolic Engineering.Plants (Basel, Switzerland) · 2025Review
- Phytotherapy in Alzheimer's Disease-A Narrative Review.Biomedicines · 2024Review
- Effects of soil properties and microbial community composition on ginsenosides accumulation in farmland ginseng.Frontiers in bioengineering and biotechnology · 2024Article
- Article
- Gut Microbiota: Therapeutic Targets of Ginseng Against Multiple Disorders and Ginsenoside Transformation.Frontiers in cellular and infection microbiology · 2022Review
- Ginsenosides inActa pharmaceutica Sinica. B · 2021Review
- [Hydrophilic interaction liquid chromatography for removal of pesticide residues in ginseng extracts].Se pu = Chinese journal of chromatography · 2021Article
- Effect of Panax ginseng on preventing acute respiratory tract infection: A protocol for systematic review and meta-analysis.Medicine · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ginseng is a plant in the family Araliaceae and the genus Panax with the formal name of Panax ginseng C. A. Meyer and the treasure of traditional herbal medicine resources as the "king of herbs". Ginseng has been traditionally used for over 2,000 years in Asian countries, especially in China and Republic of Korea. During the ginseng industry chain, the cultivation in farmland and seed breeding are important for sustainable development of ginseng resources. Active components in ginseng including ginsenosides, polysaccharides, phenolic compound and their therapeutic benefits for multiple diseases are being studied. This paper aimed to review current research status and problem-solving strategies for each step of ginseng industry, including ginseng growing cultivation and seed resources, basic and clinical studies as well as comparison of ginseng industry between China and Republic of Korea, hoping to provide a reference for research direction and future development of ginseng industry.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.